Skip to Content

Correction: Pitavastatin (Livalo) - The Seventh Statin

In issue 1343, the usual decrease in LDL-cholesterol with pitavastatin (Livalo) in the table on page 58 should have been 35-40% with 2 mg and 40-45% with 4 mg. Also, in the paragraph on Dosage and Administration, the definition of moderately decreased renal function should have been 30-<60 mL/min/1.73 m2.


This article has been freely provided.

If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Correction: Pitavastatin (Livalo) - The Seventh Statin
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1344
Article Code: 1344d
Date: August 9, 2010
Volume: 52
Page: 64

 Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.
 Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.
This article is not available for purchase.